NBT
BIIB icon

Northwest Bank & Trust’s Biogen BIIB Stock Holding History

Northwest Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$459K Buy
2,855
+34
+1% +$5.74K 0.34% 69
2024
Q3 		$547K Sell
2,821
-9
-0.3% -$1.88K 0.42% 60
2024
Q2 		$656K Sell
2,830
-429
-13% -$93.2K 0.55% 50
2024
Q1 		$700K Sell
3,259
-14
-0.4% -$3.28K 0.64% 44
2023
Q4 		$847K Buy
+3,273
New +$804K 0.76% 40
2023
Q2 		$928K Buy
+3,258
New +$970K 0.89% 30

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northwest Bank & Trust's BIIB Position: Q4 2024 in Review

Northwest Bank & Trust increased its Biogen (BIIB) stake by 1.2% in Q4 2024, buying an estimated $5.74K and bringing the position to 2,855 shares worth $459K. The position accounts for 0.34% of the portfolio, ranked #69.

Northwest Bank & Trust first reported a position in BIIB in Q2 2023 and has held it in 6 quarters since. The position peaked at $928K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Northwest Bank & Trust held 2,855 shares of Biogen worth $459K as of Q4 2024.
  • Northwest Bank & Trust bought 34 Biogen shares in Q4 2024, an estimated $5.74K.
  • Biogen made up 0.34% of Northwest Bank & Trust's portfolio in Q4 2024, its #69 holding.
  • Northwest Bank & Trust first reported a position in Biogen in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's Biogen position peaked at $928K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.